Resectoscope Devices Market To Reach $565.65 Million By 2030

Resectoscope Devices Market Growth & Trends

The global resectoscope devices market size is anticipated to reach USD 565.65 million by 2030, and it is anticipated to expand at a CAGR of 5.36% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market's growth can be attributed to factors such as developing healthcare infrastructure, growing geriatric population, increasing awareness about urological and gynecological health, and the rising prevalence of urogenital diseases.

As conditions such as benign prostatic hyperplasia, urinary incontinence, and bladder cancer become more common, the demand for surgical interventions utilizing resectoscopes has increased. For instance, according to the American Cancer Society’s estimates for bladder cancer in the U.S. for 2024, about 83,190 new cases of bladder cancer (about 63,070 in men and 20,120 in women) and about 16,840 deaths from bladder cancer (about 12,290 in men and 4,550 in women). International Agency for Research on Cancer, bladder cancer ranks as the ninth most prevalent cancer globally.

In 2022, over 600,000 individuals were diagnosed with this type of cancer, and more than 220,000 succumbed to the disease. While most cases are identified at an early stage when treatment is highly effective, approximately 25% of bladder cancers are detected at more advanced stages. These devices, which combine endoscopic technology with surgical instrumentation, are essential for procedures involving the resection of tissue from the uterus, prostate, bladder, and urethra. The ability of resectoscopes to provide real-time visualization during surgery enhances their utility and effectiveness, thereby positively impacting their adoption in healthcare facilities.

In addition, the development of healthcare infrastructure is allowing enhanced access to these advanced devices, allowing more patients to receive necessary treatments. For instance, in September 2024, Summit Health launched two new multi-specialty healthcare facilities in Fair Lawn and Bridgewater, New Jersey. These centers will offer a range of services, including urology and gynecology, enhancing access to comprehensive care for local communities and improving patient experience with state-of-the-art amenities. This trend is expected to continue as healthcare systems evolve and prioritize minimally invasive surgical options, thereby contributing to market growth.

Moreover, the increasing investments in healthcare systems in emerging economies, such as countries in Asia Pacific and Latin America are allowing them to upgrade their medical equipment to address rising patient populations. This has led increase in demand for resectoscope devices, supported by training initiatives for surgeons to enhance procedural outcomes.

 Request a free sample copy or view report summary: Resectoscope Devices Market Report

Resectoscope Devices Market Report Highlights

• On the basis of device type, the bipolar resectoscope segment held the largest market share in 2024. This is attributed to their advantages over other alternatives such as superior safety profile, and clinical effectiveness.

• On the basis of application, the urology segment held the largest market share in 2024. This is attributed to the rising prevalence of conditions such as benign prostatic hyperplasia (BPH) and bladder cancer.

• On the basis of end use, the hospitals segment dominated the market with largest market share in 2024. This is due to the increasing adoption of these devices in hospitals and increasing number of hospital facilities globally.

• North America dominates the market with largest market share in 2024.

Resectoscope Devices Market Segmentation

Grand View Research has segmented the global resectoscope devices market on the basis of on device type, application, end-use, and region:

Resectoscope Device Type Outlook (Revenue, USD Million, 2018 - 2030)

• Monopolar Resectoscopes

• Bipolar Resectoscopes

• Plasma Resectoscopes

• Hybrid Resectoscopes

Resectoscope Application Outlook (Revenue, USD Million, 2018 - 2030)

• Urology

• Gynecology

• General Surgery

Resectoscope End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Ambulatory Surgical Centers (ASCs)

• Specialty Clinics

• Others

Resectoscope Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Thailand

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Resectoscope Devices Market

• Olympus

• Stryker

• KARL STORZ SE & Co. KG

• Advin Health Care

• Richard Wolf GmbH.

• Orion Medical

• Bissinger Medizintechnik

• Ayush Surgical Co.

• Golden Nimbus International

• JDmeditech